Generate a tailored SOP for Dr. Michael Crowley. Improve your application with a focused, well-structured draft.
Michael Crowley is an Adjunct Professor at the College of Pharmacy with over 30 years of experience in drug delivery and pharmaceutical research. He is the co-founder and currently serves as President of Theridian Technologies, a consulting company specializing in drug delivery and product development. Prior to his role at Theridian, he was the Vice President of Business Development at PharmaForm. His tenure at PharmaForm included multiple senior management positions, focusing on Quality Control, Analytical Research, and Development, as well as Drug Delivery Technology and Manufacturing Services. Earlier in his career, Dr. Crowley held management roles at Monsanto Company, Warner-Jenkinson Company, and Mission Pharmacal. He has an extensive background in physical pharmacy and pharmaceutical technology, with research interests particularly concentrated on novel drug delivery systems. Dr. Crowley has contributed significantly to the field through peer-reviewed publications and has presented his work at both national and international scientific conferences. He has also authored chapters in the 2005 and 2012 editions of Remington: Science and Practice of Pharmacy and has co-invented five patents. In addition to his research contributions, he actively serves as a reviewer for various scientific journals.
General requirements for the Graduate School at UT Austin apply to all programs unless otherwise specified.